Display options
Share it on

Neuropsychiatr Dis Treat. 2018 Oct 09;14:2583-2591. doi: 10.2147/NDT.S176301. eCollection 2018.

Upregulation of vitamin D-related genes in schizophrenic patients.

Neuropsychiatric disease and treatment

Fateme Asadzadeh Manjili, Seyed Mehdi Kalantar, Shahram Arsang-Jang, Soudeh Ghafouri-Fard, Mohammad Taheri, Arezou Sayad

Affiliations

  1. Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  2. Reproductive and Genetic Unit, Recurrent Abortion Research Center, Yazd Reproductive Science Institute, Yazd University of Medical Sciences, Yazd, Iran.
  3. Clinical Research Development Center (CRDU), Qom University of Medical Sciences, Qom, Iran.
  4. Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, [email protected]; [email protected].
  5. Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, [email protected].

PMID: 30349256 PMCID: PMC6186300 DOI: 10.2147/NDT.S176301

Abstract

INTRODUCTION: Low level of vitamin D is a potential risk factor for developing schizophrenia. Through interaction with its receptor (

METHODS: In this case-control study, relative expression of

RESULTS: Significant upregulations were observed in

CONCLUSION: We hypothesized that the observed upregulation of the mentioned genes in schizophrenia patients might be the result of a compensatory mechanism to protect the affected individuals against adverse consequences of this disorder. Such imbalance in vitamin D processing pathway might also be implicated in the pathogenesis of schizophrenia. However, future studies should be designed to confirm the results of the current study.

Keywords: CYP24A1; CYP27B1; VDR; schizophrenia

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. Schizophr Res. 2018 Feb;192:226-231 - PubMed
  2. Neurobiol Aging. 2009 Mar;30(3):466-73 - PubMed
  3. Schizophr Res. 2014 Nov;159(2-3):543-5 - PubMed
  4. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):538-45 - PubMed
  5. Curr Opin Neurobiol. 2009 Apr;19(2):220-30 - PubMed
  6. Schizophr Res. 2017 Sep;187:74-81 - PubMed
  7. Front Cell Neurosci. 2013 Mar 27;7:31 - PubMed
  8. FASEB J. 2015 Jun;29(6):2207-22 - PubMed
  9. Mult Scler. 2009 Nov;15(11):1280-5 - PubMed
  10. Schizophr Res. 2012 Feb;134(2-3):211-8 - PubMed
  11. Ther Adv Psychopharmacol. 2014 Dec;4(6):268-75 - PubMed
  12. Trends Endocrinol Metab. 2002 Apr;13(3):100-5 - PubMed
  13. Metab Brain Dis. 2018 Jun;33(3):933-937 - PubMed
  14. Minerva Med. 2012 Oct;103(5):383-91 - PubMed
  15. J Neuropathol Exp Neurol. 2013 Feb;72(2):91-105 - PubMed
  16. J Neuroimmunol. 2011 Jun;235(1-2):91-7 - PubMed
  17. Curr Psychiatry Rep. 2014 Nov;16(11):502 - PubMed
  18. Annu Rev Nutr. 2014;34:117-41 - PubMed
  19. Eur Arch Psychiatry Clin Neurosci. 2004 Feb;254(1):14-22 - PubMed
  20. Schizophr Res. 2017 Jul;185:58-66 - PubMed
  21. Neuropathol Appl Neurobiol. 2013 Aug;39(5):458-84 - PubMed
  22. Schizophr Res. 2001 Mar 1;48(1):137-44 - PubMed
  23. Schizophr Res. 2016 Sep;176(1):52-71 - PubMed
  24. Mult Scler Relat Disord. 2018 Jan;19:15-19 - PubMed
  25. Neurosci Biobehav Rev. 2011 Jan;35(3):878-93 - PubMed
  26. J Biol Chem. 2014 Apr 25;289(17):11681-94 - PubMed
  27. FASEB J. 2014 Jun;28(6):2398-413 - PubMed
  28. Schizophr Res. 2016 Dec;178(1-3):44-49 - PubMed
  29. Schizophr Res. 2016 Sep;176(1):41-51 - PubMed
  30. Biochim Biophys Acta. 2011 Jan;1814(1):186-99 - PubMed
  31. Trends Biochem Sci. 2004 Dec;29(12):664-73 - PubMed
  32. J Neurochem. 1999 Aug;73(2):859-66 - PubMed
  33. Metab Brain Dis. 2017 Oct;32(5):1537-1542 - PubMed
  34. Biochem Biophys Res Commun. 2015 Apr 24;460(1):53-71 - PubMed

Publication Types